The STEP 1 trial (N=1,961) published in the New England Journal of Medicine in 2021 (DOI: 10.1056/NEJMoa2032183) demonstrated 14.9% mean body weight reduction with semaglutide 2.4mg weekly versus 2.4% with placebo over 68 weeks
See the glass vials, protective packaging, and impressive quality for yourself!
Ding J, Lu B, Liu L, Zhong Z, Wang N, Li B, et al
In our experience, patients with a subacute tendinopathy that has stalled at 6 to 12 weeks of physical therapy tend to notice a meaningful change in pain and range of motion within 3 to 4 weeks of starting a BPC-157 protocol
Rather than relying primarily on caffeine, Limitless uses a multi-pathway approach with ingredients that support neurotransmitters, memory, stress resilience, brain energy metabolism, and neuroprotectionproviding comprehensive cognitive support instead of just a temporary energy boost